Allegro Pharmaceuticals, LLC

United States of America

 
Total IP 18
Total IP Rank # 82,943
IP Activity Score 2/5.0    15
IP Activity Rank # 56,944

Patents

Trademarks

9 0
5 0
4 0
0
 
Last Patent 2024 - Treatments for diseases and diso...
First Patent 2010 - Compositions and methods for inh...

Latest Inventions, Goods, Services

2023 Invention Treatments for diseases and disorders that involve oxidative stress. Peptide compounds and their...
Invention Treatments for diseases and disorders that involve oxidative stress. Peptide compounds and their ...
2022 Invention Inhibition of tumor necrosis factor, pro-inflammatory cytokines and other inflammatory response m...
2021 Invention Treatments for improving or lessening impairment of mitochondrial function. Peptide therapies to ...
Invention Treatments for improving or lessening impairment of mitochondrial function. Peptide therapies to...
2020 Invention Therapeutic and neuroprotective peptides. Nonnatural peptides and their methods of use in human ...
Invention Peptides for treating non-exudative macular degeneration and other disorders of the eye. Methods...
Invention Peptides for treating non-exudative macular degeneration and other disorders of the eye. Uses of ...
Invention Pharmaceutical compositions and preparations for administration to the eye. 3H)COOH) and derivati...
Invention Peptide therapies for reduction of macular thickening. 5-Integrin, inhibiting cellular adhesion t...
2019 Invention Peptides useable for treatment of disorders of the eye. 3H)COOH) and derivatives thereof, includi...
2018 Invention Therapeutic and neuroprotective peptides. Nonnatural peptides and their methods of use in human o...
Invention Peptides useable for treating cancer. 5-Integrin, inhibiting cellular adhesion to RGD binding sit...
Invention Compositions and methods for inhibiting cellular adhesion or directing diagnostic or therapeutic ...
2012 Invention Integrin receptor antagonists and their methods of use. 5-Integrin, inhibiting cellular adhesion ...
Invention Integrin receptor antagonists and their methods of use. Compounds comprising R-G-Cysteic Acid (i....
2010 Invention Peptide compositions and therapeutic uses thereof. 3H)COOH) and derivatives thereof, including ph...